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The worldwide structural genomics initiative promises, within the
next decade, to provide us with the three-dimensional structures of
most representative proteins. However, the initiative does not in
the initial stages specifically address the structural basis of pro-
tein-protein interactions and protein regulation, both of which are
crucial for understanding the cellular function of proteins. This re-
port reviews the studies of the structural basis of protein-protein
interactions and regulation in several biologically important cellu-
lar processes carried out in our laboratory. The focus will be on the
recognition of nuclear localization sequences (NLSs) by the nuclear
import factor importin-, and its regulation. Regulatory interac-
tions in retroviral envelope proteins and the enzyme phenylalanine
hydroxylase (PAH) will be discussed also. All three biological sys-
tems share a regulatory mechanism termed active site-directed or
intrasteric regulation.
Key words: active site-directed/intrasteric regulation, importin-/
karyopherin-, membrane fusion, nuclear localization signal, phe-
nylalanine hydroxylase, protein-protein interactions, protein struc-
ture, viral envelope proteins, X-ray crystallography.
INTRODUCTION
The function of a protein molecule depends on its three-dimensional
structure. It is becoming increasingly clear that structure does not only ex-
plain the known functional properties of a protein, but that much can be in-
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ferred about the function of a protein (with yet unknown function) from know-
ing its structure. This observation forms the foundation of a new field of
structural biology termed »structural genomics«, a systematic program of
high-throughput structure determination aimed at determining the structu-
re of a representative protein from every protein family.1 Several structural
genomics initiatives have started worldwide and are already producing va-
luable data.
Most proteins in the cell, however, do not function on their own; they in-
teract with other proteins and other molecules such as DNA, RNA and small
molecule ligands. Furthermore, many proteins are regulated in complex
ways, and enzymes catalyze complex chemical reactions. Studies of these
aspects of protein function are poorly covered by structural genomics. Our
laboratory has been especially interested in understanding the structural
basis of protein-protein interactions and protein regulation, using primarily
X-ray crystallography, and combining this method with biophysical, bio-
chemical and molecular biology techniques that yield quantitative informa-
tion on the interactions and link structural properties to functional aspects.
Our integrated approach to studying protein-protein interactions will be il-
lustrated by our work on the process of protein import into the cell nucleus,
the metabolic enzyme phenylalanine hydroxylase, and the mechanism of
membrane fusion catalyzed by retroviral fusion proteins.
THE ROLE OF IMPORTIN- IN THE PROCESS
OF NUCLEAR IMPORT
Unlike bacterial cells, all eukaryotic cells contain a cell nucleus. Many
important processes, including transcription, occur in the nucleus. However,
proteins are synthesized in the cytoplasm, and proteins that function in the
nucleus need to be transported there. The nucleus is separated from the cy-
toplasm by a double membrane termed the nuclear envelope. The transport
occurs through nuclear pore complexes (NPCs), large complex structures
that penetrate the double lipid layer of the nuclear envelope. Most macro-
molecules require an active, signal-mediated transport process. The first
and best characterized nuclear targeting signals are the classical nuclear lo-
calization sequences (NLSs) that contain one or more clusters of basic ami-
no acids.2 The NLSs do not conform to a specific consensus sequence, and
fall into two distinct classes termed monopartite NLSs, containing a single
cluster of basic amino acids, and bipartite NLSs, containing two basic clus-
ters.
Despite the variability, the classical NLSs are recognized by the same
receptor protein termed importin or karyopherin, a heterodimer of  and 
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subunits.3 Importin- (Imp) contains the NLS-binding site and importin-
(Imp) is responsible for the translocation of the importin-substrate complex
through the NPC (Figure 1). The transfer through the pore is facilitated by
the proteins Ran (Ras-related nuclear protein) and nuclear transport fac-
tor-2 (NTF2). Once inside the nucleus, Imp binds to Ran-GTP, which
causes the dissociation of the import complex and the autoinhibition of Imp;
the importin subunits return to the cytoplasm separately without the im-
port cargo. The directionality of nuclear import is thought to be conferred by
an asymmetric distribution of the GTP- and GDP-bound forms of Ran be-
tween the cytoplasm and the nucleus. This distribution is in turn controlled
by various Ran-binding regulatory proteins.
To understand the variety of interactions formed by Imp during a cycle
of protein import, we set out to determine the crystal structures of Imp
and its complexes with peptides corresponding to NLSs, and characterize
the interactions using surface plasmon resonance on a BIAcore biosensor.
The first structure we determined was of the intact, recombinantly expres-
sed mouse Imp.4 The structure of a truncated yeast Imp published some-
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Figure 1. Schematic diagram of the NLS-dependent nuclear import pathway. Impor-
tin-, oval grey object »«; importin-, light-grey object »«; NLS-containing cargo
protein, white pentagonal object »NLS«; Ran-GTP, round dark-grey object »Ran
GTP«. For simplicity, other factors involved in the pathway such as NTF2, the nu-
clear export receptor for importin- and Ran-binding proteins have been omitted
from the diagram. Dissociation constants for the different binding events, based on
our surface plasmon resonance results,7 are shown.
what earlier 5 provided the opportunity to compare the two proteins, and re-
vealed an interesting function for the N-terminal region of the protein. It
was previously established that Imp consists of two functional domains, a
short N-terminal domain involved in Imp binding (»IBB« domain), and a
large C-terminal domain involved in NLS binding. While the IBB domain
was not present in the yeast Imp used for structure determination, our
structure revealed that the IBB domain interacted with the NLS binding si-
te, autoinhibiting the protein (Figure 2).
Our structural observation suggested that Imp uses a so-called intra-
steric or active site-directed mechanism of regulation.6 In the nucleus, Imp
exists as a monomeric protein and binding to nuclear proteins containing
NLSs is not desired; the autoinhibitory IBB domain therefore prevents the
binding of various nuclear proteins. Once transported to the cytoplasm,
however, Imp binds to the IBB domain, removing it from the NLS-binding
site and activating Imp. In the cytoplasm, the Imp-Imp complex can
therefore collect NLS-containing proteins destined for the nucleus and tran-
sport them there. Once the trimeric transport complex reaches the nucleus,
however, the protein Ran-GTP binds to Imp and displaces Imp. Imp can
therefore release its cargo, and return to the cytoplasm without Imp or the
cargo protein for the next cycle of import.
The model of regulation of nuclear import suggested based on our struc-
ture is supported by our affinity measurements using the BIAcore biosensor,
and analogous experiments using different techniques by other groups (Ref.
808 B. KOBE
70
496
44
54
Figure 2. Structure of mouse importin-.4 Ribbon diagram of importin- is shown
(Figures 2, 4 and 5 are drawn with programs MOLSCRIPT and RASTER3D).21,22
The N-terminal autoinhibitory segment is the region between residues 44 and 54.
7, and references therein). There appears to be an at least 250-fold increase
in affinity for NLS binding by Imp if Imp is present. We are further test-
ing the regulatory mechanism using site-directed mutagenesis and nuclear
import assays.
It used to be puzzling how a single receptor protein, Imp, can bind a di-
verse set of NLSs including monopartite ones such as the NLS from the sim-
ian virus 40 large T-antigen (T-Ag; PKKRKV, single letter amino acid code),
and bipartite ones such as the NLS from nucleoplasmin (KRPAATKKAGQA-
KKK). Furthermore, either group of NLSs has very diverse sequences, with
no obvious consensus sequence. Our structures of complexes of mouse Imp
with peptides corresponding to NLSs,8 and similar studies on the yeast pro-
tein,9 have now resolved this puzzle. The two clusters of basic residues in bi-
partite NLSs bind to two distinct regions on the surface of Imp, using elec-
PROTEIN-PEPTIDE BINDING AND REGULATION 809
Figure 3. Schematic diagram of the interactions of NLS peptides with importin-.
The NLS backbone is shown as a thick horizontal line, with the side chains shown as
perpendicular lines radiating from it. The NLS-binding domain of importin- has a
repetitive amino acid sequence pattern termed armadillo repeats, each repeat corre-
sponding to a structural unit comprising three -helices in the crystal structure;4 in-
dividual armadillo repeats are separated by tilted lines in the Figure. Some impor-
tin- side chains interacting with the NLS peptides are indicated: the invariant
asparagines, the invariant tryptophans, and some nearby negatively charged resi-
dues. Y277 and R315 that interrupt the regular asparagine and tryptophan array
are also shown.
trostatic, polar and hydrophobic interactions, while the linker sequence
between the two clusters makes fewer favorable contacts and therefore does
not need to be highly conserved. We have determined structures of comple-
xes of Imp with peptides corresponding to several different bipartite NLSs
and find that the linker sequence can form a diverse set of interactions, de-
pending on its sequence and length (unpublished results). The basic cluster
in monopartite NLSs can use either basic cluster binding site for binding,
but the one used by the C-terminal region of the bipartite NLSs appears to
be the high affinity site. The binding strategy used is extremely elegant,
and explains the »promiscuous specificity« of NLS binding; individual side
chain-binding pockets can often accommodate either a lysine or arginine re-
sidue, determining the specificity of binding, but the strongest interactions
appear to be made by the main chain of the peptide. A schematic represen-
tation of the binding is shown in Figure 3.
Phosphorylation in the vicinity of NLSs sequences in some proteins pro-
vides yet another level of complexity and the opportunity to finely regulate
nuclear import.10 One system under complex control by phosphorylation is
the T-Ag; phosphorylation N-terminal to the NLS increases the efficiency of
nuclear import. Our preliminary studies on the structure of the complex of
the phosphorylated and un-phosphorylated peptides corresponding to the
relevant region of T-Ag with Imp reveals an intricate mechanism of regula-
tion that will require further studies to be fully understood (unpublished re-
sults).
REGULATION OF PHENYLALANINE HYDROXYLASE
Phenylalanine hydroxylase (PAH) is a metabolic enzyme that converts
phenylalanine to tyrosine using molecular oxygen, enzyme-bound iron, and
a 6R-tetrahydrobiopterin (BH4) cofactor.
11 It is a member of the aromatic
amino acid hydroxylase family, together with tyrosine hydroxylase (TH) and
tryptophan hydroxylase (TPH); TH and TPH are involved in the biosynthe-
sis of the neurotransmitters, L-DOPA and serotonin, respectively. The aro-
matic amino acid hydroxylases share a similar enzyme mechanism and have
a common three-domain structure consisting of an N-terminal regulatory
domain, a catalytic domain and a C-terminal tetramerization domain; the
highest sequence and structural similarity is found in the catalytic domain.
Over 300 different mutations in the PAH gene have been found to be associ-
ated with the disease phenylketonuria (PKU).12
PAH, TH and TPH are regulated in different ways, and their regulatory
domains are not highly conserved. PAH needs to be regulated very tightly,
because it keeps under control the level of phenylalanine, an essential ami-
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no acid, which is subject to large fluctuations due to dietary intake. On the
one hand, the levels of PAH in the liver are such that if uncontrolled, the en-
zyme would rapidly deplete the phenylalanine stores; on the other hand, the
metabolites of phenylalanine are toxic to the developing brain. The major
regulatory mechanisms of PAH include activation by phenylalanine, inhibi-
tion by BH4, and additional activation by phosphorylation.
11 Activation by
the substrate phenylalanine is considered the major regulatory event, and
its binding induces large conformational changes. Activation by phenylala-
nine and phosphorylation act synergistically; the phosphorylated protein re-
quires a lower concentration of phenylalanine for activation, and the phe-
nylalanine-activated protein is more rapidly phosphorylated by cAMP-
dependent protein kinase.
To understand the complex mechanisms regulating this important en-
zyme, we determined the crystal structure of rat PAH lacking the C-termi-
nal, 24-residue tetramerization domain (PAH1–428); the truncation of the C-
terminal residues was necessary for reproducible crystallization, but it did
not affect the regulatory and catalytic properties of the enzyme 13,14 (Figure
4). The structure revealed the expected two domains; a C-terminal catalytic
domain, and an N-terminal regulatory domain. The most interesting obser-
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Figure 4. Structure of phenylalanine hydroxylase.14 Ribbon diagram of a monomer
of PAH1-428 is shown. The disordered residues 137–142 are indicated by a straight
thin line. The side chains of the iron-binding residues (His285, His290 and Glu330)
and the ferric ion are also shown.
vation was that the very N-terminal sequence comprising amino acids 19–
29 reached into the active site of the catalytic domain. As was the case above
with Imp, the sequence appeared to autoinhibit the enzyme.6 We tested
this autoinhibitory role of the N-terminal sequence by expressing a protein
lacking the 29 N-terminal amino acids (PAH30–428) and confirmed that
PAH30–428 was constitutively active (i.e. it does not require phenylalanine
activation) and showed an altered structural response to phenylalanine.15
Similar results were obtained using PAH lacking the first 26 residues.16
Another surprising observation revealed by the structure of PAH1–428
was that residues 1–18, containing the phosphorylation site Ser16, showed
no defined structure in both phosphorylated and un-phosphorylated forms;14
this was difficult to reconcile with the established role of phosphorylation in
activating the enzyme.11 We used nuclear magnetic resonance (NMR) to fol-
low the dynamics of the N-terminal mobile region. Our results confirm that
this region is mobile in absence of phenylalanine, but a significant loss of
mobility is observed for a portion of the sequence after the addition of phe-
nylalanine, suggesting that upon activation the N-terminal sequence beco-
mes associated with the folded core of the molecule (unpublished results).
Our results suggest a model where the binding of phenylalanine to its regu-
latory site causes conformational changes, during which the N-terminal se-
quence moves away from the active site, with phosphorylation aiding this
transition through stabilizing the phenylalanine-activated form. However, a
structural characterization of the various ligand-bound states will be requi-
red for a complete understanding of the regulation of PAH.
MECHANISM OF RETROVIRAL MEMBRANE FUSION
Enveloped viruses, including the human pathogenic viruses such as in-
fluenza virus and the retroviruses HIV (human immunodeficiency virus)
and HTLV (human T cell leukemia virus), fuse their membranes with host
cell membranes to enable the transfer of their genome into the host cell.17
Envelope glycoproteins (Env) are responsible for the attachment and subse-
quent membrane fusion of virions and infected cells with target cells. Env
comprises a receptor-binding subunit (SU) associated with a transmembra-
ne protein (TM). Envelope glycoproteins are synthesized as precursors and
are processed in the Golgi apparatus to yield a mature functional SU/TM
complex. The mature Env proteins are incorporated into budding virions at
the plasma membrane. Retroviral entry into cells follows SU-mediated at-
tachment to cellular receptors and TM-mediated fusion between the viral
envelope and target cellular membrane. Cell surface-localized Env proteins
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can also mediate cell-to-cell retrovirus transmission by fusion between in-
fected cells and target cells.
We used a combination of crystal structure analysis and site-directed
mutagenesis to study the Env protein from HTLV type 1 (HTLV-1). HTLV-1
is associated with various diseases including adult T-cell leukemia/lympho-
ma, HTLV-1-associated myelopathy/tropical spastic paraparesis, uveitis and
infectious dermatitis of children.18 We determined the crystal structure of
the HTLV-1 TM ectodomain,19 and used in vitro mutagenesis to test the func-
tional role of structural elements observed in the gp21 structure.20
The ectodomain of gp21, the TM from HTLV-1, was crystallized as a mal-
tose-binding protein (MBP) chimera and the MBP domain was used to solve
the structure by the method of molecular replacement. The structure of
gp21 comprises an N-terminal trimeric coiled coil, an adjacent disulfide-
bonded loop that stabilizes a chain reversal, and a C-terminal sequence that
packs against the coil in an extended anti-parallel fashion (Figure 5). The
structure reveals both similarities and differences with TM fragments of
other retroviruses such as human immunodeficiency virus (HIV), orthomy-
xoviruses such as influenza virus, a filovirus Ebola virus and a paramyxo-
virus, simian virus 5.17 All these structures are long rods containing a cen-
tral trimeric coiled coil and a chain reversal, which would imply that the
hydrophobic N-terminal fusion peptide responsible for host cell membrane
attachment, and the C-terminal transmembrane sequence anchored in the
viral envelope, are juxtaposed at one end of the rod. These observations sug-
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Figure 5. Structure of HTLV-1 gp21.19 Ribbon diagram of the HTLV-1 gp21 ectodo-
main trimer is shown. The side chains of selected residues are also shown. The N-
and the C-termini are indicated; the fusion peptides would be located at the N-ter-
mini, and the membrane anchors would be located at the C-termini. The maltose
binding protein fusion partner used for crystallization is not shown.
gest that these structures represent a fusion-activated or post-fusion confor-
mation. Our structure, jointly with all other available information, suggests
a model for the mechanism of membrane fusion.19 In this model, the SU/TM
complex initially exists in a metastable, pre-fusion conformation, where the
N-terminal fusion peptide and the C-terminal membrane anchor are at dif-
ferent ends of the complex. Host cell receptor binding by the SU subunit
(e.g. in retroviruses) or a pH change (e.g. in influenza virus) triggers confor-
mational changes, during which the N-terminal fusion peptide binds to the
host cell membrane, followed by an anti-parallel packing of the C-terminal
segment against the exterior of the coiled coil to provide energy for the relo-
cation and juxtaposition of the C-terminal transmembrane anchors with the
N-terminal fusion peptides. This rearrangement causes a perturbation of
the two membranes that results in their subsequent fusion.
We further studied the structural basis of membrane fusion by assessing
the functional consequences of mutating residues within the key structural
elements of gp21 that are conserved in retroviral and filoviral TM hair-
pins.20 We identified functional roles for a hydrophobic structure that caps
the N-terminus of the central coiled coil, the region of chain reversal at the
C-terminus of the coiled coil, and the sites of interaction between the C-ter-
minal ectodomain segment and the coiled coil. We find that membrane fu-
sion activity requires the stabilization of the N- and C-termini of the central
coiled coil by a hydrophobic N-cap and a small hydrophobic core, respecti-
vely. A conserved Gly-Gly hinge motif preceding the disulfide-bonded loop, a
salt bridge that stabilizes the chain reversal region and interactions betwe-
en the C-terminal segment and the coiled coil are also critical for fusion ac-
tivity. Our data support a model whereby the chain reversal region trans-
mits a conformational signal from receptor-bound SU to induce the fusion-
activated helical hairpin conformation of TM.
The Env-mediated process of membrane fusion has obvious parallels
with the process of intrasteric regulation. While in the systems under intra-
steric control an autoregulatory sequence autoinhibits the function of the
protein through binding to its active site, in viral TM proteins the C-termi-
nal sequence analogous to an autoregulatory sequence binds to the coiled
coil to drive membrane fusion.
CONCLUSIONS
Protein-protein interactions and protein regulation are essential compo-
nents of the complex networks functioning in cells, and understanding the
molecular basis of these processes is crucial for piecing together a detailed
map of cellular pathways. The work by our group has focused on a few spe-
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cific systems where we can learn about the fundamental aspects of these
processes, and we are delighted to see that our work has some general im-
plications for a variety of other processes in the cell.
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SA@ETAK
Intramolekulske samoreguliraju}e sekvencije u proteinima
Bostjan Kobe
Op}esvjetska inicijativa strukturne genomike obe}ava priskrbiti nam trodimen-
zijske strukture ve}ine zna~ajnih proteina za idu}ih deset godina. Ipak, ta inicijativa
u po~etnim stadijima nije posebno usmjerena na strukturnu bazu interakcija pro-
tein-protein i proteinsku regulaciju, a to je oboje bitno za razumijevanje stani~ne
funkcije proteina. Ovaj prikaz daje pregled na{ih istra`ivanja strukturnih temelja
interakcija protein-protein i regulacije u nekoliko biolo{ki va`nih stani~nih procesa.
U `ari{tu je prepoznavanje jezgrovnih (nuklearnih) lokalizacijskih sekvencija (NLSs)
s jezgrovnim importnim faktorom importinom- i njegova regulacija. Tako|er se
diskutira o regulacijskoj interakciji proteina retrovirusne ovojnice i enzima fenil-
alaninhidroksilaze (PAH). Svim je tim sustavima zajedni~ki mehanizam intra-
steri~ke regulacije koji je odre|en aktivnim mjestom.
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